Mylan Pharms. Inc. v. Merck Sharp & Dohme Corp. United States Court of Appeals of the Federal Circuit, 2022 50 F.4th 147.

Saved in:
Bibliographic Details
Title: Mylan Pharms. Inc. v. Merck Sharp & Dohme Corp. United States Court of Appeals of the Federal Circuit, 2022 50 F.4th 147.
Authors: HOLMAN, CHRISTOPHER M.1 (AUTHOR)
Source: Biotechnology Law Report. Dec2022, Vol. 41 Issue 6, p305-310. 6p.
Database: Business Source Ultimate
Description
ISSN:0730031X
DOI:10.1089/blr.2022.29290.cip